Valuation: CeriBell, Inc.

Market Cap 879M 762M 714M 651M 1.23B 83.91B 1.25B 8.41B 3.28B 42.01B 3.3B 3.23B 140B P/E 2026 *
-11.6x
P/E 2027 * -14.7x
Enterprise Value 884M 766M 718M 655M 1.23B 84.38B 1.25B 8.46B 3.3B 42.24B 3.32B 3.25B 141B EV / Sales 2026 *
7.66x
EV / Sales 2027 * 6.18x
Free-Float
87.16%
Yield 2026 *
-
Yield 2027 * -
1 day+1.48%
1 week+27.12%
Current month+31.43%
1 month+18.87%
3 months+38.81%
6 months+16.60%
Current year+6.02%
1 week 18.2
Extreme 18.2
23.5
1 month 15.96
Extreme 15.96
23.5
Current year 15.84
Extreme 15.84
24.33
1 year 10.85
Extreme 10.85
24.33
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2014-08-28
Chairman 57 2014-08-28
Director/Board Member 64 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
8/3/26 Fiscal year

Founder

89,000 0.2346%
7/28/26 Free

Director

16,011 0.0422%
7/28/26 Free

Director

16,011 0.0422%
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%+27.12%+98.72% - 879M
-1.75%-1.08%-24.14%+5.82% 4.13B
-0.93%+10.69%+84.56% - 1.64B
+0.40%+9.58%+80.79%+72.73% 131M
-0.99%-7.41%-21.88%-30.55% 56.27M
Average -0.36%+8.06%+43.61%+16.00% 1.37B
Weighted average by Cap. -1.09%+6.59%+19.76%+7.37%

Financials

2026 *2027 *
Net sales 115M 100M 93.83M 85.56M 161M 11.02B 164M 1.1B 431M 5.52B 434M 424M 18.4B 147M 127M 120M 109M 205M 14.04B 208M 1.41B 549M 7.03B 552M 540M 23.44B
Net income -75.94M -65.83M -61.71M -56.27M -106M -7.25B -108M -727M -284M -3.63B -285M -279M -12.1B -61.91M -53.66M -50.31M -45.87M -86.31M -5.91B -87.69M -592M -231M -2.96B -232M -227M -9.87B
Net Debt 4.85M 4.2M 3.94M 3.59M 6.76M 463M 6.87M 46.37M 18.1M 232M 18.2M 17.8M 772M 29.76M 25.79M 24.18M 22.05M 41.48M 2.84B 42.15M 285M 111M 1.42B 112M 109M 4.74B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-08-13 US$23.25 +1.48% 510,393
26-08-12 US$22.91 +7.51% 531,712
26-08-11 US$21.31 +10.41% 1,859,769
26-08-10 US$19.30 +2.60% 424,074
26-08-07 US$18.81 +3.07% 262,793
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
22.91USD
Average target price
27.00USD
Spread / Average Target
+17.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock